Literature DB >> 29061776

Update on Nanotechnology-based Drug Delivery Systems in Cancer Treatment.

Benjamin N Ho1, Claire M Pfeffer1, Amareshwar T K Singh2.   

Abstract

The emerging field of nanotechnology meets the demands for innovative approaches in the diagnosis and treatment of cancer. The nanoparticles are biocompatible and biodegradable and are made of a core, a particle that acts as a carrier, and one or more functional groups on the core which target specific sites. Nanotech in drug delivery includes nanodisks, High Density Lipoprotein nanostructures, liposomes, and gold nanoparticles. The fundamental advantages of nanoparticles are: improved delivery of water-insoluble drugs, targeted delivery, co-delivery of two or more drugs for combination therapy, and visualization of the drug delivery site by combining imaging system and a therapeutic drug. One of the potential applications of nanotechnology is in the treatment of cancer. Conventional methods for cancer treatments have included chemotherapy, surgery, or radiation. Early recognition and treatment of cancer with these approaches is still challenging. Innovative technologies are needed to overcome multidrug resistance, and increase drug localization and efficacy. Application of nanotechnology to cancer biology has brought in a new hope for developing treatment strategies on cancer. In this study, we present a review on the recent advances in nanotechnology-based approaches in cancer treatment. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  HDL nanostructures; Nanodisks; cancer; gold nanoparticles; liposomes; nanodiamonds; review

Mesh:

Substances:

Year:  2017        PMID: 29061776     DOI: 10.21873/anticanres.12044

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

Review 1.  Drug Delivery of Natural Products Through Nanocarriers for Effective Breast Cancer Therapy: A Comprehensive Review of Literature.

Authors:  Kah Min Yap; Mahendran Sekar; Shivkanya Fuloria; Yuan Seng Wu; Siew Hua Gan; Nur Najihah Izzati Mat Rani; Vetriselvan Subramaniyan; Chandrakant Kokare; Pei Teng Lum; M Yasmin Begum; Shankar Mani; Dhanalekshmi Unnikrishnan Meenakshi; Kathiresan V Sathasivam; Neeraj Kumar Fuloria
Journal:  Int J Nanomedicine       Date:  2021-12-02

Review 2.  Nanomaterials for Protein Delivery in Anticancer Applications.

Authors:  Anne Yau; Jinhyung Lee; Yupeng Chen
Journal:  Pharmaceutics       Date:  2021-01-25       Impact factor: 6.321

Review 3.  Application Potential of Plant-Derived Medicines in Prevention and Treatment of Platinum-Induced Peripheral Neurotoxicity.

Authors:  Xiaowei Xu; Liqun Jia; Xiaoran Ma; Huayao Li; Changgang Sun
Journal:  Front Pharmacol       Date:  2022-01-13       Impact factor: 5.810

4.  Milk-exosome based pH/light sensitive drug system to enhance anticancer activity against oral squamous cell carcinoma.

Authors:  Qian Zhang; Qi Xiao; Honglin Yin; Chengwan Xia; Yumei Pu; Zhifeng He; Qingang Hu; Jianquan Wang; Yuxin Wang
Journal:  RSC Adv       Date:  2020-07-29       Impact factor: 3.361

Review 5.  Nanotechnology: A Promising Approach for Cancer Diagnosis, Therapeutics and Theragnosis.

Authors:  Mesfin Dessale; Getachew Mengistu; Hylemariam Mihiretie Mengist
Journal:  Int J Nanomedicine       Date:  2022-08-26

6.  Effect of a 2-HP-β-Cyclodextrin Formulation on the Biological Transport and Delivery of Chemotherapeutic PLGA Nanoparticles.

Authors:  Kangyu Zheng; Xiangmei Liu; Junfeng Ban; Zeju Huang; Jiaying Huang; Xin Huang; Haosen Luo; Zhicong Chen; Qingchun Xie; Yanzhong Chen; Zhufen Lu
Journal:  Drug Des Devel Ther       Date:  2021-06-17       Impact factor: 4.162

7.  Assessment of Anti-Tumor potential and safety of application of Glutathione stabilized Gold Nanoparticles conjugated with Chemotherapeutics.

Authors:  Karol P Steckiewicz; Ewelina Barcinska; Katarzyna Sobczak; Ewelina Tomczyk; Michał Wojcik; Iwona Inkielewicz-Stepniak
Journal:  Int J Med Sci       Date:  2020-03-12       Impact factor: 3.738

8.  Delivery of siRNA to Ewing Sarcoma Tumor Xenografted on Mice, Using Hydrogenated Detonation Nanodiamonds: Treatment Efficacy and Tissue Distribution.

Authors:  Sandra Claveau; Émilie Nehlig; Sébastien Garcia-Argote; Sophie Feuillastre; Grégory Pieters; Hugues A Girard; Jean-Charles Arnault; François Treussart; Jean-Rémi Bertrand
Journal:  Nanomaterials (Basel)       Date:  2020-03-19       Impact factor: 5.076

Review 9.  Current Trends in ATRA Delivery for Cancer Therapy.

Authors:  Maria Valeria Giuli; Patrizia Nadia Hanieh; Eugenia Giuliani; Federica Rinaldi; Carlotta Marianecci; Isabella Screpanti; Saula Checquolo; Maria Carafa
Journal:  Pharmaceutics       Date:  2020-07-28       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.